Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Ligand Pharmaceuticals Incorporated (LGND) had Weighted-Average Shares Outstanding (Diluted) of 19.93M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$47.63M |
|
$4.85M |
|
$2.91M |
|
$44.72M |
|
$39.18M |
|
$8.44M |
|
$2.78M |
|
$11.22M |
|
$10.28M |
|
$4.85M |
|
$4.85M |
|
$4.85M |
|
$3.37M |
|
$8.44M |
|
$16.32M |
|
19.33M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
19.93M |
$0.25 |
|
$0.24 |
|
| Balance Sheet Financials | |
$352.94M |
|
$3.63M |
|
$595.66M |
|
$948.60M |
|
$64.73M |
|
-- |
|
$55.34M |
|
$120.08M |
|
$828.53M |
|
$476.86M |
|
$828.53M |
|
19.41M |
|
| Cash Flow Statement Financials | |
$-9.65M |
|
$-5.77M |
|
$10.25M |
|
$72.31M |
|
$67.67M |
|
$-4.64M |
|
$17.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.45 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
93.90% |
|
17.73% |
|
17.73% |
|
-- |
|
23.56% |
|
10.18% |
|
$-11.89M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.19 |
|
0.91 |
|
99.00 |
|
0.58% |
|
1.02% |
|
0.51% |
|
0.58% |
|
$42.68 |
|
$-0.60 |
|
$-0.48 |
|